,,ii  #aaf? ,,congress  #a/ ,session    
,s4 #adcg  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,may #ac1 #bjai,mr4    
,durb9 7= himself1 ,mr4 ,grassley1 ,mr4 
,k+1 & ,mr4 ,alex&]7 introduc$ ! foll[+ 
bill2 :i* 0 read twice & ref]r$ to !    
,committee on ,f9ance  ,a ,,bill  ,to   
am5d title ,,xi ( ! ,social ,security   
,act to require t direct-to-consum]     
adv]tisem5ts = prescription drugs &     
biological products include tru?ful &   
non-mislead+ pric+ in=mation4  #a4 ,%ort
 title ,?is ,act may be cit$ z !        
,drug-price ,transp>5cy 9               
,communications 7,,dtc7 ,act4  #b4      
,f9d+s ,congress f9ds ! foll[+3 7#a7    
,direct-to-consum] adv]tis+ (           
prescription ph>maceuticals is legally  
p]mitt$ 9 only #b develop$ c\ntries1 !  
,unit$ ,/ates & ,new ,zeal&4  7#b7 ,9   
#bjah1 ph>maceutical ad sp5d+ exce$$    
#f1jdf1jjj1jjj1 a #d4h-p]c5t increase   
ov] #bjag1 result+ 9 ! av]age ,am]ican  
see+ #i drug adv]tisem5ts p] day4  7#c7 
,9 #bjae1 ph>maceutical companies sp5t m

 ?an #ajj1jjj1jjj on adv]tis+ ) respect 
to ea* ( ! #af mo/ adv]tis$ br&-"n drugs
 & biological products1 prim>ily new &  
relatively high-co/ m$ications4  7#d7 ,!
 #aj mo/ commonly adv]tis$ drugs h li/  
prices rang+ f #ece to #aa1jjj p]       
#cj-;day supply or usual c\rse ( !rapy4 
7#e7 ,accord+ to a #bjaa ,congressional 
,budget ,(fice report1 direct-to-consum]
 adv]tis+ is us$ to promote only a small
 set ( specific drugs1 typically !      
exp5sive1 br&-"n m$ications4 ,& !       
top-sell+ drugs 9 any giv5 ye> are      
frequ5tly among ! drugs ) ! l>ge/       
exp5ditures = direct-to-consum]         
adv]tis+4  7#f7 ,accord+ to a #bjaa     
,congressional ,budget ,(fice report1   
ph>maceutical manufactur]s adv]tise _!  
products directly to consum]s 9 an      
attempt to boo/ dem& = _! products &    
!reby raise ! price t consum]s are will+
 to pay1 increase ! quantity ( drugs    
sold1 or a*ieve "s comb9ation ( ! two4  
7#g7 ,/udies %[ t pati5ts are m likely  
to ask _! doctor = a specific m$ication 

& = ! doctor to write a prescription =  
x1 if a pati5t has se5 an adv]tisem5t = 
su* m$ication1 reg>dless ( :e!r !       
m$ication is cl9ically appropriate = !  
pati5t or :e!r a l[]-co/ g5]ic may be   
available4  7#h7 ,accord+ to a #bjaa    
,congressional ,budget ,(fice report1 ! 
av]age numb] ( prescriptions writt5 =   
newly approv$ br&-"n drugs )            
direct-to-consum] adv]tis+ 0 #i times   
great] ?an ! av]age numb] (             
prescriptions writt5 = newly approv$    
br&-"n drugs )\t direct-to-consum]      
adv]tis+4  7#i7 ,approximately half (   
,am]icans h high-d$uctible heal? plans1 
"u :i* !y (t5 pay ! li/ price ( a drug  
until _! insurance d$uctible is met4    
,all ( ! top ,m$ic>e prescription drug  
plans use co9surance r ?an fix$-doll>   
copaym5ts = m$ications on nonpref]r$    
drug ti]s4  7#aj7 ,! ,c5t]s = ,m$ic>e   
,m$icaid ,s]vices is ! s+le l>ge/ drug  
pay] 9 ! ,nation4 ,drug price inflation 
acc\nts = a significant portion ( !     
#bb-p]c5t1 #cb-p]c5t1 & #db-p]c5t gr[? 9

 ,m$ic>e p>ts ,d & ,b & ,m$icaid        
exp5ditures1 respectively1 on a p]      
b5efici>y basis betwe5 #bjac & #bjaf4   
7#aa7 ,! #bj mo/ adv]tis$ drugs on      
television co/ ,m$ic>e & ,m$icaid a     
comb9$ #bd1jjj1jjj1jjj 9 #bjag4  7#ab7  
,price %opp+ is ! m>k ( rational        
economic behavior1 & m>kets op]ate m    
effici5tly :5 consum]s h relevant       
in=mation ab\t a product1 includ+ its   
price1 be=e mak+ an in=m$ decision ab\t 
:e!r to buy t product4  7#ac7 ,!        
,am]ican ,m$ical ,association has pass$ 
resolutions support+ ! requirem5t =     
price transp>5cy 9 any direct-to-consum]
 adv]tis+4  7#ad7 ,! ,kais] ,family     
,f\ndation f\nd t #hh p]c5t ( ! public  
favors ! ,f$]al ,gov]nm5t requir+       
prescription drug adv]tisem5ts to       
include a /atem5t on h[ mu* ! drug co/s4
  7#ae7 ,pursuant to its exi/+ au?ority 
"u sections #aajb & #ahga ( ! ,social   
,security ,act1 on ,may #aj1 #bjai1 !   
,c5t]s = ,m$ic>e  ,m$icaid ,s]vices     
publi%$ regulations 7subp>t ,l ( "p #djc

 ( title #db1 ,code ( ,f$]al            
,regulations7 to require                
direct-to-consum] television            
adv]tisem5ts ( prescription drugs &     
biological products = :i* paym5t is     
available ?r\gh or "u ,m$ic>e or        
,m$icaid to include ! :olesale          
acquisition co/ ( t drug or biological  
product4  7#af7 ,to support ! p]man5ce &
 cl>ity ( ?is policy1 & to facilitate   
future plann+1 ,congress f9ds a b5efit  
to codify+ su* regulation4  #c4         
,requirem5t t direct-to-consum]         
adv]tisem5ts = prescription drugs &     
biological products include tru?ful &   
non-mislead+ pric+ in=mation ,"p ,a (   
title ,,xi ( ! ,social ,security ,act is
 am5d$ by add+ at ! end ! foll[+ new    
section3  #aaej;,c4 ,requirem5t t       
direct-to-consum] adv]tisem5ts =        
prescription drugs & biological products
 include tru?ful & non-mislead+ pric+   
in=mation  7a7 ,9 g5]al ,! ,secret>y    
%all require t ea* direct-to-consum]    
adv]tisem5t = a prescription drug or    

biological product = :i* paym5t is      
available "u title ,,xviii or ,,xix     
includes an appropriate disclosure (    
tru?ful & non-mislead+ pric+ in=mation )
 respect to ! drug or product4  7b7     
,det]m9ation by ,,cms ,! ,secret>y1 act+
 ?r\gh ! ,adm9i/rator ( ! ,c5t]s =      
,m$ic>e  ,m$icaid ,s]vices1 %all det]m9e
 ! compon5ts ( ! requirem5t "u          
subsection 7a71 su* z ! =ms ( adv]tis+1 
! mann] ( disclosure1 ! price po9t li/+1
 & ! price in=mation = disclosure4  4